SAB Biotherapeutics Inc. (SABS) PE Ratio
SAB Biotherapeutics Inc. (SABS) PE ratio history, current valuation, and earnings analysis. Track price-to-earnings trends in Excel with MarketXLS.
PE Ratio Data
| Period | PE Ratio |
|---|---|
| 2020-12-31 | 4.70 |
| 2021-12-31 | -0.59 |
| 2022-12-31 | -8.63 |
| 2023-12-31 | -0.49 |
| 2024-12-31 | -1.01 |
Get SAB Biotherapeutics Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =PERatio("SABS")
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SABS | $3.71 | -1.33% | 0.15M |
| 3 | ||||
| 4 | ||||
| 5 |